Jaume Pons

Jaume Pons

Company: ALX Oncology

Job title: Chief Scientific Officer


Considering the Rationale Behind Developing Combination Therapies to Maximize their Potential Effectiveness 1:30 pm

Strategizing the logical design of a combination therapy to enhance the efficacy of your macrophage-directed therapy Weighing up the benefits and drawbacks of combination therapies to grasp their appeal Reviewing the costs and other limiting factors associated with combination therapiesRead more

day: Conference Day One

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.